Regeneron Pharmaceuticals Operating Expenses 2011-2025 | REGN

Annual Operating Expenses Regeneron Pharmaceuticals

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	-	4.87 B	3.74 B	3.4 B	3.23 B	2.46 B	1.78 B	1.19 B	836 M	647 M

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
4.87 B	647 M	2.46 B

Operating Expenses of other stocks in the Biotechnology industry

Issuer	Operating Expenses	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	432 M	-	2.43 %	$ 254 M	Germany
Arbutus Biopharma Corporation ABUS	96.2 M	$ 4.75	-0.94 %	$ 788 M	Canada
Aclaris Therapeutics ACRS	92.7 M	$ 3.05	0.16 %	$ 236 M	USA
Aeglea BioTherapeutics AGLE	209 M	-	-	$ 1.01 B	USA
Alpine Immune Sciences ALPN	88.2 M	-	-	$ 2.17 B	USA
AlloVir ALVR	65.4 M	-	4.14 %	$ 49.1 M	USA
Alexion Pharmaceuticals, Inc. ALXN	2.66 B	-	-	$ 40.3 B	USA
Aptorum Group Limited APM	20.7 M	$ 1.17	-	$ 6.38 M	China
Ampio Pharmaceuticals AMPE	9.57 M	-	-11.43 %	$ 502 K	USA
EyeGate Pharmaceuticals, Inc. EYEG	8.22 M	-	-1.52 %	$ 24.7 M	USA
Applied Molecular Transport AMTI	127 M	-	-	$ 10.1 M	USA
Midatech Pharma plc MTP	4.78 M	-	-18.52 %	$ 27.3 M	Britain
Ascendis Pharma A/S ASND	338 M	$ 209.68	-1.47 %	$ 5 B	Danmark
Aptevo Therapeutics APVO	-31.8 M	$ 0.6	-35.15 %	$ 166 K	USA
Alterity Therapeutics Limited ATHE	16.7 M	$ 3.16	2.1 %	$ 7.6 B	Australia
BioVie BIVI	18.1 M	$ 1.18	-7.09 %	$ 1.74 M	USA
Athersys ATHX	79.8 M	-	3.77 %	$ 22.4 M	USA
Институт стволовых клеток человека ISKJ	629 M	-	-	-	Russia
Avenue Therapeutics ATXI	5.21 K	-	-52.27 %	$ 4.45 M	USA
ARCA biopharma ABIO	88.1 M	-	1052.0 %	$ 415 M	USA
AVROBIO AVRO	71.7 M	-	1083.1 %	$ 745 M	USA
Acasti Pharma ACST	24.4 M	-	4.01 %	$ 150 M	Canada
Adaptimmune Therapeutics plc ADAP	141 M	-	-15.15 %	$ 60.3 M	Britain
BioDelivery Sciences International BDSI	106 M	-	-4.8 %	$ 255 M	USA
Albireo Pharma ALBO	163 M	-	-0.23 %	$ 916 M	USA
BioNTech SE BNTX	512 M	$ 94.23	-0.84 %	$ 27.2 B	Germany
Amphastar Pharmaceuticals AMPH	168 M	$ 26.87	0.22 %	$ 1.3 B	USA
BeiGene, Ltd. BGNE	390 M	-	0.49 %	$ 251 B	Cayman-islands
Can-Fite BioPharma Ltd. CANF	14 M	$ 0.22	25.66 %	$ 479 M	Israel
Anika Therapeutics ANIK	51.6 M	$ 9.49	0.13 %	$ 139 M	USA
Bellicum Pharmaceuticals BLCM	28.5 M	-	-9.72 %	$ 5.89 M	USA
Berkeley Lights BLI	152 M	-	-7.31 %	$ 87 M	USA
bluebird bio BLUE	854 M	-	-	$ 546 M	USA
Arena Pharmaceuticals ARNA	427 M	-	-6.81 %	$ 3.04 B	USA
Acer Therapeutics ACER	24.6 M	-	2.71 %	$ 14 M	USA
Calithera Biosciences CALA	125 M	-	-10.95 %	$ 876 K	USA
Axon Enterprise AXON	1.18 B	$ 587.62	-0.6 %	$ 44.5 B	USA
Ayala Pharmaceuticals AYLA	29.8 M	-	-	$ 7.46 M	Israel
Aytu BioScience AYTU	53.7 M	$ 2.48	-1.98 %	$ 15.6 M	USA
AstraZeneca PLC AZN	17.6 B	$ 92.58	0.14 %	$ 96.9 B	Britain
Acorda Therapeutics ACOR	206 M	-	-24.86 %	$ 820 K	USA
Catalyst Biosciences CBIO	176 M	$ 12.49	0.95 %	$ 822 M	USA
Brickell Biotech BBI	14.4 M	-	-5.38 %	$ 6.06 M	USA
Celldex Therapeutics CLDX	58.1 M	$ 26.14	-2.57 %	$ 1.68 M	USA
Burford Capital Limited BUR	106 M	$ 9.02	0.17 %	$ 1.48 B	Britain
Cellectar Biosciences CLRB	15.3 M	$ 2.59	-6.34 %	$ 31.7 M	USA
Biohaven Pharmaceutical Holding Company Ltd. BHVN	1.07 B	$ 10.86	0.51 %	$ 702 M	USA
Biogen BIIB	5.39 B	$ 175.92	-0.23 %	$ 25.6 B	USA
Cerevel Therapeutics Holdings CERE	447 M	-	-	$ 7.29 B	USA